1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Thailand Pharmaceuticals and Healthcare Report Q1 2016

Thailand Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 99 pages

Includes 3 FREE quarterly updates

BMI View: Developing into a regional hub for pharmaceutical R&D will remain a challenge for Thailand.The government has yet to implement a national level strategy to foster the sector's growth and is unlikelyto do so in the short term as the military junta focuses on staying in power. As such, funding constraints,limitations in scientific human capital and low levels of investment into research by domestic firms willpersist, weighing on the sector's R&D prospects.

Headline Expenditure Projections

- Pharmaceuticals: THB145.5bn (USD4.5bn) in 2014 to THB152.9bn (USD4.4bn) in 2015; +5.1% inlocal currency terms and -1.1% in US dollar terms.
- Healthcare: THB581.7bn (USD17bn) in 2014 to THB621.3bn (USD18bn) in 2015: +6.8% in localcurrency and +-0.5% in US dollar terms.

Table Of Contents

Thailand Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Thailand 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Thailand 2011-2019) 13
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2011-2019) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2011-2019) 16
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Thailand 2011-2019) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Thailand 2011-2019) 20
Generic Drug Market Forecast 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Thailand 2011-2019) 22
OTC Medicine Market Forecast 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Thailand 2011-2019) 24
Pharmaceutical Trade Forecast 24
Table: Pharmaceutical Trade Data And Forecasts (Thailand 2013-2019) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Thailand 2013-2019) 27
Industry Risk/Reward Index 28
Asia Pacific Risk/Reward Index 28
Thailand Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Intellectual Property Issues 40
Pricing Regime 41
Table: Price Build-Up Of Medicines In Thailand 42
Reimbursement Regime 42
Market Overview 44
Healthcare Sector 44
Table: Major Health Insurance Programmes In Thailand 46
Table: Healthcare Resources (Thailand 2009-2014) 47
Table: Healthcare Personnel (Thailand 2009-2014) 48
Table: Healthcare Activity (Thailand 2009-2014) 48
Clinical Trials 50
Epidemiology 51
Table: Estimated Number Of New Cases Of Cancer In Thailand 55
Competitive Landscape 56
Research Based Industry 56
Table: PReMA Members 56
Table: Multinational Market Activity 57
Generic Drugmakers 58
Table: Pharmaceutical Manufacturers Of Modern Drugs, 2007-2012 59
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 60
Company Profile 63
Berlin Pharmaceutical Industry 63
Biolab 66
GlaxoSmithKline 68
Government Pharmaceutical Organisation 71
Merck and Co 75
Novartis 78
Pfizer 81
Sanofi 85
Demographic Forecast 88
Table: Population Headline Indicators (Thailand 1990-2025) 89
Table: Key Population Ratios (Thailand 1990-2025) 89
Table: Urban/Rural Population and Life Expectancy (Thailand 1990-2025) 90
Table: Population By Age Group (Thailand 1990-2025) 90
Table: Population By Age Group % (Thailand 1990-2025) 91
Glossary 93
Methodology 95
Pharmaceutical Expenditure Forecast Model 95
Healthcare Expenditure Forecast Model 95
Notes On Methodology 96
Risk/Reward Index Methodology 97
Index Overview 98
Table: Pharmaceutical Risk/Reward Index Indicators 98
Indicator Weightings 99

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.